Mining Whole-liver Information with Deep Learning for Preoperatively Predicting HCC Recurrence-free Survival

被引:1
|
作者
Huang, Chao [1 ]
Hu, Peijun [1 ]
Tian, Yu [2 ]
Gao, Yiwei [1 ]
Wang, Yangyang [3 ]
Zhang, Qi [3 ]
Liang, Tingbo [3 ]
Li, Jingsong [1 ,2 ]
机构
[1] Zhejiang Lab, Res Ctr Healthcare Data Sci, Hangzhou, Peoples R China
[2] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Engn Res Ctr EMR & Intelligent Expert Syst, Minist Educ, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou, Peoples R China
来源
2023 45TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY, EMBC | 2023年
基金
中国国家自然科学基金;
关键词
D O I
10.1109/EMBC40787.2023.10340426
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Hepatocellular carcinoma ( HCC) is globally a leading cause of cancer death. Non-invasive pre-operative prediction of HCC recurrence-free survival (RFS) after resection is essential but remains challenging. Previous models based on medical imaging focus only on tumor area while neglecting the whole liver condition. In fact, HCC patients usually suffer from chronic liver diseases which also hamper the patient survival. This work aims to develop a novel convolutional neural network (CNN) to mine whole-liver information from contrast-enhanced computed tomography (CECT) to predict RFS after hepatic resection in HCC. Our proposed RFSNet takes liver regions from CECT as input, and outputs a risk score for each patient. Cox proportional-hazards loss was applied for model training. A total of 215 patients with primary HCC and treated with hepatic resection were included for analysis. Patients were randomly split into developing subcohort and testing subcohort by 4:1. The developing subcohort was further split into the training subcohort and validation subcohort for model training. Baseline models were built with tumor region, radiomics features and/or clinical features the same as previous tumor-based approaches. Results showed that RFSNet achieved the best performance with concordance-indinces (CIs) of 0.88 and 0.65 for the developing and testing subcohorts, respectively. Adding clinical features did not improve RFSNet. Our findings suggest that the proposed RFSNet based on whole liver is able to extract more valuable information concerning RFS prognosis compared to features from only tumor and the clinical indicators.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Two cases of colorectal liver metastasis with residual liver recurrence after a long recurrence-free survival period
    Shotaro Yagi
    Makoto Takahashi
    Taiki Tsuji
    Susumu Yanagibashi
    Taku Higashihara
    Hideo Ohtsuka
    Tatsuya Hayashi
    Kunio Takuma
    Yasuhiro Morita
    Ayano Nakazono
    Haruka Okada
    Masayuki Ohtsuka
    Surgical Case Reports, 9
  • [22] Two cases of colorectal liver metastasis with residual liver recurrence after a long recurrence-free survival period
    Yagi, Shotaro
    Takahashi, Makoto
    Tsuji, Taiki
    Yanagibashi, Susumu
    Higashihara, Taku
    Ohtsuka, Hideo
    Hayashi, Tatsuya
    Takuma, Kunio
    Morita, Yasuhiro
    Nakazono, Ayano
    Okada, Haruka
    Ohtsuka, Masayuki
    SURGICAL CASE REPORTS, 2023, 9 (01)
  • [23] Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases
    Andrea Muratore
    Dario Ribero
    Giuseppe Zimmitti
    Alfredo Mellano
    Serena Langella
    Lorenzo Capussotti
    Annals of Surgical Oncology, 2010, 17 : 1324 - 1329
  • [24] Glioblastoma whole transcriptome analysis: molecular mechanisms related to recurrence-free survival (RFS)
    Franceschi, Sara
    Lessi, Francesca
    Aretini, Paolo
    Carbone, Francesco G.
    Scatena, Cristian
    La Feria, Marco
    Ortenzi, Valerio
    Vannozzi, Riccardo
    Bevilacqua, Generoso
    Naccarato, Antonio G.
    Mazzanti, Chiara M.
    CANCER RESEARCH, 2015, 75
  • [25] Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases
    Muratore, Andrea
    Ribero, Dario
    Zimmitti, Giuseppe
    Mellano, Alfredo
    Langella, Serena
    Capussotti, Lorenzo
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1324 - 1329
  • [26] Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
    Feng, Long-Hai
    Zhu, Yu-Yao
    Zhou, Jia-Min
    Wang, Miao
    Xu, Wei-Qi
    Zhang, Ti
    Mao, An-Rong
    Cong, Wen-Ming
    Dong, Hui
    Wang, Lu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Multitask deep learning for prediction of microvascular invasion and recurrence-free survival in hepatocellular carcinoma based on MRI images
    Wang, Fang
    Zhan, Gan
    Chen, Qing-qing
    Xu, Hou-yun
    Cao, Dan
    Zhang, Yuan-yuan
    Li, Yin-hao
    Zhang, Chu-jie
    Jin, Yao
    Ji, Wen-bin
    Ma, Jian-bing
    Yang, Yun-jun
    Zhou, Wei
    Peng, Zhi-yi
    Liang, Xiao
    Deng, Li-ping
    Lin, Lan-fen
    Chen, Yen-wei
    Hu, Hong-jie
    LIVER INTERNATIONAL, 2024, 44 (06) : 1351 - 1362
  • [28] RECURRENCE-FREE LONG-TERM SURVIVAL AFTER LIVING DONOR LIVER TRANSPLANTATION FOR HCC IS INDEPENDENT FROM CLINICAL TUMOR MACROMORPHOLOGY
    Kornberg, Arno
    Kuepper, Bernadett
    Thrum, Katharina
    Wilberg, Jens
    Buechler, Peter
    Habrecht, Olaf
    Friess, Helmut
    Krause, Babette
    TRANSPLANT INTERNATIONAL, 2011, 24 : 167 - 168
  • [29] A unique gene signature predicting recurrence-free survival in stage IA lung adenocarcinoma
    Carr, Shamus R.
    Wang, Haitao
    Hudlikar, Rasika
    Lu, Xiaofan
    Zhang, Mary R.
    Hoang, Chuong D.
    Yan, Fangrong
    Schrump, David S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 165 (04):
  • [30] Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Li, Yinuo
    Hou, Xin
    Chen, Wei
    Wang, Shixuan
    Ma, Xiangyi
    SCIENTIFIC REPORTS, 2023, 13 (01)